Tropical Storm Rafael, which is expected to strengthen and may hit the Gulf Coast later this week, could further disrupt the IV solution supply chain if its path shifts towards Texas, where 4.4% of U.

Telehealth platform Hims & Hers will begin offering a generic version of liraglutide, a GLP-1 weight loss drug, to its customers in 2025, Quartz reported Nov. 4.

Hims & Hers (HIMS) stock price remained on edge even after the fast-growing telehealth company published strong financial ...

Hims & Hers' both revenue channels witness strong revenue growth on the back of solid product demand in the third quarter.

Boeing workers on the U.S. West Coast ended a seven-week strike after approving a contract that includes a 38% wage increase over four years. The strike, which impacted 737 MAX production and other ...

There is also a chance that a weaker macroeconomy and slowing consumer spending may encourage more consumers to review their ...

Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS), the leading health and wellness platform, today announced financial results for the third quarter ended September 30, 2024 in a ...

If you’re looking to prevent hair loss or stop the progression of any hair loss that’s started, a topical product can help.

Buy HIMS near 17.07 target 21.33 stop loss @ 17.02 Details The technical summary data tells us to buy HIMS near 17.07 with an ...

Hims & Hers Health Inc. said an analysis of more than 10,000 patients taking a copycat version of Novo Nordisk A/S’s Ozempic and Wegovy showed the shot was a safe and effective way to shed pounds.